Clinical trial
Defining an Endopheneotype for Alcohol Treatment With Naltrexone
NCT00817089 is registered in ClinicalTrials.gov with University of Pennsylvania as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Defining an Endopheneotype for Alcohol Treatment With Naltrexone
- Lead sponsor
- University of Pennsylvania
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- December 31, 2007
- Completion date
- June 30, 2010
- Enrollment
- 24 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.